Dow Down 1.10% Nasdaq Down 1.82%

Inovio Pharmaceuticals, Inc. (INO)

-NasdaqGS
6.00 Down 0.01(0.17%) 4:00PM EST
|After Hours : 6.00 Up 0.01 (0.17%) 4:00PM EST - Nasdaq Real Time Price
Prev Close:6.01
Open:5.99
Bid:5.45 x 2000
Ask:6.24 x 600
1y Target Est:20.20
Beta:2.39284
Earnings Date:Mar 14 - Mar 18 (Est.)
Day's Range:5.75 - 6.07
52wk Range:4.50 - 10.83
Volume:2,238,673
Avg Vol (3m):1,749,950
Market Cap:433.10M
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INODown 0.17%433.10M
PFEDown 1.62%176.32B
AZNDown 4.46%72.53B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.70
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.40
Quarterly EPS Est (Dec-15) :-0.20
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback